Skip to main content

Articles

Page 126 of 163

  1. Malaria Rapid Diagnostic Tests (RDTs) are widely used to diagnose malaria. The present study evaluated a new RDT, the Clearview® Malaria pLDH test targeting the pan-Plasmodium antigen lactate dehydrogenase (pLDH)...

    Authors: Sandrine Houzé, Véronique Hubert, Dorit Pessler Cohen, Baruch Rivetz and Jacques Le Bras
    Citation: Malaria Journal 2011 10:284
  2. Recently, Plasmodium falciparum parasites bearing Pfdhfr I164L single mutation were found in Madagascar. These new mutants may challenge the use of antifolates for the intermittent preventive treatment of malaria...

    Authors: Valérie Andriantsoanirina, Rémy Durand, Bruno Pradines, Eric Baret, Christiane Bouchier, Arsène Ratsimbasoa and Didier Ménard
    Citation: Malaria Journal 2011 10:283
  3. Reports of severe cases and increasing levels of drug resistance highlight the importance of improved Plasmodium vivax case management. Whereas monitoring P. vivax resistance to anti-malarial drug by in vivo and

    Authors: Céline Barnadas, David Kent, Lincoln Timinao, Jonah Iga, Laurie R Gray, Peter Siba, Ivo Mueller, Peter J Thomas and Peter A Zimmerman
    Citation: Malaria Journal 2011 10:282
  4. Following the development of resistance to anti-malarial mono-therapies, malaria endemic countries in Africa now use artemisinin-based combination therapy (ACT) as recommended first-line treatment for uncompli...

    Authors: Harriet Lawford, Dejan Zurovac, Laura O'Reilly, Sarah Hoibak, Alice Cowley, Stephen Munga, John Vulule, Elizabeth Juma, Robert W Snow and Richard Allan
    Citation: Malaria Journal 2011 10:281
  5. It is controversial to what degree α+-thalassaemia protects against episodes of uncomplicated malaria and febrile disease due to infections other than Plasmodium.

    Authors: Jacobien Veenemans, Esther JS Jansen, Amrish Y Baidjoe, Erasto V Mbugi, Ayşe Y Demir, Rob J Kraaijenhagen, Huub FJ Savelkoul and Hans Verhoef
    Citation: Malaria Journal 2011 10:280
  6. Malaria still remains a life-threatening disease worldwide causing between 190 and 311 million cases of malaria in 2008. Due to increased resistance to sulphadoxine-pyrimethamine (SP), the Ministry of Health i...

    Authors: Linda V Kalilani-Phiri, Douglas Lungu and Renia Coghlan
    Citation: Malaria Journal 2011 10:279
  7. Parasite clearance rates are important measures of anti-malarial drug efficacy. They are particularly important in the assessment of artemisinin resistance. The slope of the log-linear segment in the middle of...

    Authors: NJ White
    Citation: Malaria Journal 2011 10:278
  8. Malaria is one of the leading causes of sickness and death in the developing world, causing more than a million deaths and around 250 million new cases annually worldwide. The aim of this comprehensive survey ...

    Authors: Mahdi Mohammadi, Alireza Ansari-Moghaddam, Ahmad Raiesi, Fatemeh Rakhshani, Fatemeh Nikpour, Aliakbar Haghdost, Mansoor Ranjbar, Rahim Taghizadeh-Asl, Mohammad Sakeni, Reza Safari and Mehdi Saffari
    Citation: Malaria Journal 2011 10:277
  9. The characterization of malaria parasite populations circulating in an area is part of site characterization, as a basis for evaluating the impact of malaria interventions on genetic diversity, parasite specie...

    Authors: Pembe Issamou Mayengue, Mathieu Ndounga, Freddy Vladimir Malonga, Michel Bitemo and Francine Ntoumi
    Citation: Malaria Journal 2011 10:276
  10. Sulphadoxine-pyrimethamine, in combination with artesunate or amodiaquine, is recommended for the treatment of uncomplicated malaria and is being evaluated for intermittent preventive treatment. Yet, limited d...

    Authors: Mamadou M Tekete, Sékou Toure, Alfia Fredericks, Abdoul H Beavogui, Cheick PO Sangare, Alicia Evans, Peter Smith, Hamma Maiga, Zoumana I Traore, Ogobara K Doumbo, Karen I Barnes and Abdoulaye A Djimde
    Citation: Malaria Journal 2011 10:275
  11. Developing resistance towards existing anti-malarial therapies emphasize the urgent need for new therapeutic options. Additionally, many malaria drugs in use today have high toxicity and low therapeutic indice...

    Authors: David J Sullivan Jr, Nikola Kaludov and Martin N Martinov
    Citation: Malaria Journal 2011 10:274
  12. The control of malaria in schools is receiving increasing attention, but there remains currently no consensus as to the optimal intervention strategy. This paper analyses the costs of intermittent screening an...

    Authors: Thomas L Drake, George Okello, Kiambo Njagi, Katherine E Halliday, Matthew CH Jukes, Lindsay Mangham and Simon Brooker
    Citation: Malaria Journal 2011 10:273
  13. The influence of host genetics on susceptibility to Plasmodium falciparum malaria has been extensively studied over the past twenty years. It is now clear that malaria parasites have imposed strong selective forc...

    Authors: Adel Driss, Jacqueline M Hibbert, Nana O Wilson, Shareen A Iqbal, Thomas V Adamkiewicz and Jonathan K Stiles
    Citation: Malaria Journal 2011 10:271
  14. Various methods have been studied as replacement of human landing catches (HLC) for mosquito sampling in entomological studies on malaria transmission. Conflicting results have been obtained in comparing relat...

    Authors: Mamadou O Ndiath, Catherine Mazenot, Ablaye Gaye, Lassana Konate, Charles Bouganali, Ousmane Faye, Cheikh Sokhna and Jean-Francois Trape
    Citation: Malaria Journal 2011 10:270
  15. The different taxa belonging to Anopheles gambiae complex display phenotypic differences that may impact their contribution to malaria transmission. More specifically, their susceptibility to infection, resulting...

    Authors: Mamadou O Ndiath, Anna Cohuet, Ablaye Gaye, Lassana Konate, Catherine Mazenot, Ousmane Faye, Christian Boudin, Cheikh Sokhna and Jean-François Trape
    Citation: Malaria Journal 2011 10:269
  16. Decreased in vitro susceptibility to dihydroartemisinin (21.2 nM) and artesunate (16.3 nM) associated with decreased susceptibility or resistance to quinine (1131 nM), mefloquine (166 nM), lumefantrine (114 nM), ...

    Authors: Bruno Pradines, Lionel Bertaux, Christelle Pomares, Pascal Delaunay and Pierre Marty
    Citation: Malaria Journal 2011 10:268
  17. The role of brain oedema in the pathophysiology of cerebral malaria is controversial. Coma associated with severe Plasmodium falciparum malaria is multifactorial, but associated with histological evidence of para...

    Authors: Isabelle M Medana, Nicholas PJ Day, Navakanit Sachanonta, Nguyen TH Mai, Arjen M Dondorp, Emsri Pongponratn, Tran T Hien, Nicholas J White and Gareth DH Turner
    Citation: Malaria Journal 2011 10:267
  18. Malaria remains a global public health challenge. It is widely believed that an effective vaccine against malaria will need to incorporate multiple antigens from the various stages of the parasite's complex li...

    Authors: Harini D de Silva, Suha Saleh, Svetozar Kovacevic, Lina Wang, Casilda G Black, Magdalena Plebanski and Ross L Coppel
    Citation: Malaria Journal 2011 10:266
  19. During the past decade the malaria control community has been successful in dramatically increasing the number of households that own mosquito nets. However, as many as half of nets already in households go un...

    Authors: Carol A Baume and Ana Cláudia Franca-Koh
    Citation: Malaria Journal 2011 10:265
  20. In human malaria, the naturally-acquired immune response can result in either the elimination of the parasite or a persistent response mediated by cytokines that leads to immunopathology. The cytokines are res...

    Authors: Tiago S Medina, Sheyla PT Costa, Maria D Oliveira, Ana M Ventura, José M Souza, Tassia F Gomes, Antonio CR Vallinoto, Marinete M Póvoa, João S Silva and Maristela G Cunha
    Citation: Malaria Journal 2011 10:264
  21. Artesunate (AS) is a clinically versatile artemisinin derivative utilized for the treatment of mild to severe malaria infection. Given the therapeutic significance of AS and the necessity of appropriate AS dos...

    Authors: Carrie A Morris, Stephan Duparc, Isabelle Borghini-Fuhrer, Donald Jung, Chang-Sik Shin and Lawrence Fleckenstein
    Citation: Malaria Journal 2011 10:263
  22. The main vector of malaria in Solomon Islands is Anopheles farauti, which has a mainly coastal distribution. In Northern Guadalcanal, Solomon Islands, high densities of An. farauti are supported by large brackish...

    Authors: Hugo Bugoro, Jeffery Hii, Tanya L Russell, Robert D Cooper, Benny KK Chan, Charles Iro'ofa, Charles Butafa, Allen Apairamo, Albino Bobogare and Cheng-Chen Chen
    Citation: Malaria Journal 2011 10:262
  23. Insecticide resistance monitoring is essential to help national programmers to implement more effective and sustainable malaria control strategies in endemic countries. This study reported the spatial and seas...

    Authors: Innocent Djègbè, Olayidé Boussari, Aboubakar Sidick, Thibaud Martin, Hilary Ranson, Fabrice Chandre, Martin Akogbéto and Vincent Corbel
    Citation: Malaria Journal 2011 10:261
  24. Zambia has achieved significant reductions in the burden of malaria through a strategy of "scaling-up" effective interventions. Progress toward ultimate malaria elimination will require sustained prevention co...

    Authors: Ryan G Davis, Aniset Kamanga, Carlos Castillo-Salgado, Nnenna Chime, Sungano Mharakurwa and Clive Shiff
    Citation: Malaria Journal 2011 10:260
  25. Placental malaria and pre-eclampsia occur frequently in women in tropics and are leading causes of maternal and perinatal morbidities and mortality. Few data exist concerning the interaction between placental ...

    Authors: Ishag Adam, Elhassan M Elhassan, Ahmed A Mohmmed, Magdi M Salih and Mustafa I Elbashir
    Citation: Malaria Journal 2011 10:258
  26. The reemergence of Plasmodium vivax in South Korea since 1993 represents a serious public health concern. Despite the importance in understanding genetic diversity for control strategies, however, studies remain ...

    Authors: Hajime Honma, Jung-Yeon Kim, Nirianne MQ Palacpac, Toshihiro Mita, Wonja Lee, Toshihiro Horii and Kazuyuki Tanabe
    Citation: Malaria Journal 2011 10:257
  27. Rapid and fast acting anti-malarials are essential to treat severe malaria. Quinine has been the only option for parenteral therapy until recently. While current evidence shows that intravenous artesunate is m...

    Authors: Jakob P Cramer, Rogelio López-Vélez, Gerd D Burchard, Martin P Grobusch and Peter J de Vries
    Citation: Malaria Journal 2011 10:256
  28. Since 2000, under the Fifth and subsequent Framework Programmes, the European Commission has funded research to spur the development of a malaria vaccine. This funding has contributed to the promotion of an in...

    Authors: Regitze L Thøgersen, Anthony A Holder, Adrian VS Hill, David E Arnot, Egeruan B Imoukhuede and Odile Leroy
    Citation: Malaria Journal 2011 10:255
  29. In patients with malaria mixed species infections are common and under reported. In PCR studies conducted in Asia mixed infection rates often exceed 20%. In South-East Asia, approximately one third of patients...

    Authors: Mallika Imwong, Supatchara Nakeesathit, Nicholas PJ Day and Nicholas J White
    Citation: Malaria Journal 2011 10:253
  30. Immune evasion and drug resistance in malaria have been linked to chromosomal recombination and gene copy number variation (CNV). These events are ideally studied using comparative genomic analyses; however in...

    Authors: Matthew C Riley, Benjamin C Kirkup Jr, Jake D Johnson, Emil P Lesho and Christian F Ockenhouse
    Citation: Malaria Journal 2011 10:252
  31. Resistance to anti-malarial drugs is a widespread problem for control programmes for this devastating disease. Molecular tests are available for many anti-malarial drugs and are useful tools for the surveillan...

    Authors: Mahamadou Diakite, Eric A Achidi, Olivia Achonduh, Rachel Craik, Abdoulaye A Djimde, Marie-Solange B Evehe, Angie Green, Christina Hubbart, Muntasir Ibrahim, Anna Jeffreys, Baldip K Khan, Francis Kimani, Dominic P Kwiatkowski, Wilfred F Mbacham, Sabah Omar Jezan, Jean Bosco Ouedraogo…
    Citation: Malaria Journal 2011 10:250
  32. In Central and South America and Eastern and Southern Africa, Plasmodium vivax infections accounts for 71-81% and 5% of malaria cases, respectively. In these areas, chloroquine (CQ) remains the treatment of choic...

    Authors: Insaf F Khalil, Michael Alifrangis, Camilla Recke, Lotte C Hoegberg, Anita Ronn, Ib C Bygbjerg and Claus Koch
    Citation: Malaria Journal 2011 10:249
  33. Plasmodium falciparum malaria remains a leading health problem in Africa and its control is seriously challenged by drug resistance. Although resistance to the sulphadoxine-pyrimethamine (SP) is widespread, this ...

    Authors: Bianca E Gama, Guilhermina AL Pereira-Carvalho, Florbela JI Lutucuta Kosi, Natália K Almeida de Oliveira, Filomeno Fortes, Philip J Rosenthal, Virgílio E do Rosário, Cláudio Tadeu Daniel-Ribeiro and Maria de Fátima Ferreira-da-Cruz
    Citation: Malaria Journal 2011 10:248
  34. Effective mass drug administration (MDA) with anti-malarial drugs can clear the human infectious reservoir for malaria and thereby interrupt malaria transmission. The likelihood of success of MDA depends on th...

    Authors: Seif A Shekalaghe, Chris Drakeley, Sven van den Bosch, Roel ter Braak, Wouter van den Bijllaardt, Charles Mwanziva, Salimu Semvua, Alutu Masokoto, Frank Mosha, Karina Teelen, Rob Hermsen, Lucy Okell, Roly Gosling, Robert Sauerwein and Teun Bousema
    Citation: Malaria Journal 2011 10:247
  35. Malaria is a major health issue in French Guiana. Amerindian communities remain the most affected. A previous study in Camopi highlighted the predominant role of environmental factors in the occurrence of mala...

    Authors: Aurélia Stefani, Matthieu Hanf, Mathieu Nacher, Romain Girod and Bernard Carme
    Citation: Malaria Journal 2011 10:246
  36. This is an investigation of anti-malarial molecular markers coupled with a therapeutic efficacy test of chloroquine (CQ) against falciparum malaria in an area of unstable malaria in Lahj Governorate, Yemen. Th...

    Authors: Reem A Mubjer, Ahmed A Adeel, Michael L Chance and Amir A Hassan
    Citation: Malaria Journal 2011 10:245
  37. Real-time PCR is a sensitive and specific method for the analysis of Plasmodium DNA. However, prior purification of genomic DNA from blood is necessary since PCR inhibitors and quenching of fluorophores from bloo...

    Authors: Brian J Taylor, Kimberly A Martin, Eliana Arango, Olga M Agudelo, Amanda Maestre and Stephanie K Yanow
    Citation: Malaria Journal 2011 10:244
  38. Whilst some populations have recently experienced dramatic declines in malaria, the majority of those most at risk of Plasmodium falciparum malaria still lack access to effective treatment with artemisinin combin...

    Authors: Shunmay Yeung, Edith Patouillard, Henrietta Allen and Duong Socheat
    Citation: Malaria Journal 2011 10:243
  39. Pyronaridine (PN) and chloroquine (CQ) are structurally related anti-malarial drugs with primarily the same mode of action. However, PN is effective against several multidrug-resistant lines of Plasmodium falcipa...

    Authors: Kanyanan Kritsiriwuthinan, Sastra Chaotheing, Philip J Shaw, Chayaphat Wongsombat, Porntip Chavalitshewinkoon-Petmitr and Sumalee Kamchonwongpaisan
    Citation: Malaria Journal 2011 10:242
  40. Glucose-6-phosphate dehydrogenase (G6PD) deficiency is common in populations living in malaria endemic areas. G6PD genotype and phenotype were determined for malaria patients enrolled in the chlorproguanil-dap...

    Authors: Nick Carter, Allan Pamba, Stephan Duparc and John N Waitumbi
    Citation: Malaria Journal 2011 10:241
  41. The community case management of malaria (CCMm) is now an established route for distribution of artemisinin-based combination therapy (ACT) in rural areas, but the feasibility and acceptability of the approach...

    Authors: Patricia Akweongo, Peter Agyei-Baffour, Morankar Sudhakar, Bertha N Simwaka, Amadou T Konaté, Philip B Adongo, Edmund NL Browne, Ayalew Tegegn, Doreen Ali, Abdoulaye Traoré, Mary Amuyunzu-Nyamongo, Franco Pagnoni and Guy Barnish
    Citation: Malaria Journal 2011 10:240
  42. Congenital malaria has been considered a rare event; however, recent reports have shown frequencies ranging from 3% to 54.2% among newborns of mothers who had suffered malaria during pregnancy. There are only ...

    Authors: Juan G Piñeros-Jiménez, Gonzalo Álvarez, Alberto Tobón, Margarita Arboleda, Sonia Carrero and Silvia Blair
    Citation: Malaria Journal 2011 10:239
  43. Artemether-lumefantrine (ALu) replaced sulphadoxine-pymimethamine (SP) as the official first-line anti-malarial in Tanzania in November 2006. So far, artemisinin combination therapy (ACT) is contra-indicated d...

    Authors: Frank M Ringsted, Isolide S Massawe, Martha M Lemnge and Ib C Bygbjerg
    Citation: Malaria Journal 2011 10:238
  44. The use of artemisinin-based combination therapy (ACT) is currently recommended for treating uncomplicated malaria. The objective was to assess the efficacy and safety of repeated administrations of two fixed-...

    Authors: Jean-Louis A Ndiaye, Babacar Faye, Ali Gueye, Roger Tine, Daouda Ndiaye, Corinne Tchania, Ibrahima Ndiaye, Aichatou Barry, Badara Cissé, Valérie Lameyre and Oumar Gaye
    Citation: Malaria Journal 2011 10:237
  45. Malaria is a major public health issue in Burundi in terms of both morbidity and mortality, with around 2.5 million clinical cases and more than 15,000 deaths each year. It is still the single main cause of mo...

    Authors: Hermenegilde Nkurunziza, Albrecht Gebhardt and Jürgen Pilz
    Citation: Malaria Journal 2011 10:234

Annual Journal Metrics

  • 2022 Citation Impact
    3.0 - 2-year Impact Factor
    3.2 - 5-year Impact Factor
    1.148 - SNIP (Source Normalized Impact per Paper)
    1.237 - SJR (SCImago Journal Rank)

    2023 Speed
    7 days submission to first editorial decision for all manuscripts (Median)
    131 days submission to accept (Median)

    2023 Usage 
    4,093,320 downloads
    5,053 Altmetric mentions